ArticleSensors (Basel, Switzerland)2025
Enhanced Tumor Diagnostics via Cyber-Physical Workflow: Integrating Morphology, Morphometry, and Genomic MultimodalData Analysis and Visualization in Digital Pathology.
Article in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The rapid advancement of genomic technologies has significantly transformed biomedical research and clinical applications, particularly in oncology. Identifying patient-specific genetic mutations has become a crucial tool for early cancer detection and personalized treatment strategies. Detecting tumors at the earliest possible stage provides critical insights beyond traditional tissue analysis. This paper presents a novel cyber-physical system that combines high-resolution tissue scanning, laser microdissection, next-generation sequencing, and genomic analysis to offer a comprehensive solution for early cancer detection. We describe the methodologies for scanning tissue samples, image processing of the morphology of single cells, quantifying morphometric parameters, and generating and analyzing real-time genomic metadata. Additionally, the intelligent system integrates data from open-access genomic databases for gene-specific molecular pathways and drug targets. The developed platform also includes powerful visualization tools, such as colon-specific gene filtering and heatmap generation, to provide detailed insights into genomic heterogeneity and tumor foci. The integration and visualization of multimodal single-cell genomic metadata alongside tissue morphology and morphometry offer a promising approach to precision oncology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.